WO2023086938A3 - Type v nucleases - Google Patents

Type v nucleases Download PDF

Info

Publication number
WO2023086938A3
WO2023086938A3 PCT/US2022/079715 US2022079715W WO2023086938A3 WO 2023086938 A3 WO2023086938 A3 WO 2023086938A3 US 2022079715 W US2022079715 W US 2022079715W WO 2023086938 A3 WO2023086938 A3 WO 2023086938A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleases
rna guides
type
nucleic acids
acids encoding
Prior art date
Application number
PCT/US2022/079715
Other languages
French (fr)
Other versions
WO2023086938A2 (en
Inventor
David A. Scott
David R. Cheng
Winston X. YAN
Original Assignee
Arbor Biotechnologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arbor Biotechnologies, Inc. filed Critical Arbor Biotechnologies, Inc.
Publication of WO2023086938A2 publication Critical patent/WO2023086938A2/en
Publication of WO2023086938A3 publication Critical patent/WO2023086938A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The present invention relates to nucleases or nucleic acids encoding the nucleases, RNA guides or nucleic acids encoding the RNA guides, processes for characterizing the nucleases and/or RNA guides, compositions comprising the nucleases and/or RNA guides, and kits and/or methods for preparing and/or using the nucleases and/or RNA guides.
PCT/US2022/079715 2021-11-12 2022-11-11 Type v nucleases WO2023086938A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163278685P 2021-11-12 2021-11-12
US63/278,685 2021-11-12

Publications (2)

Publication Number Publication Date
WO2023086938A2 WO2023086938A2 (en) 2023-05-19
WO2023086938A3 true WO2023086938A3 (en) 2023-06-15

Family

ID=86336655

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2022/079715 WO2023086938A2 (en) 2021-11-12 2022-11-11 Type v nucleases

Country Status (1)

Country Link
WO (1) WO2023086938A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200087640A1 (en) * 2017-11-01 2020-03-19 The Regents Of The University Of California Casz compositions and methods of use
US20210324356A1 (en) * 2019-03-07 2021-10-21 The Regents Of The University Of California Crispr-cas effector polypeptides and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200087640A1 (en) * 2017-11-01 2020-03-19 The Regents Of The University Of California Casz compositions and methods of use
US20210324356A1 (en) * 2019-03-07 2021-10-21 The Regents Of The University Of California Crispr-cas effector polypeptides and methods of use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE UNIPROTKB ANONYMOUS : "A0A4R0W5F4 · A0A4R0W5F4_BIFLN", XP093072988, retrieved from UNIPROT *

Also Published As

Publication number Publication date
WO2023086938A2 (en) 2023-05-19

Similar Documents

Publication Publication Date Title
AU2018251801A8 (en) Novel type VI CRISPR orthologs and systems
WO2017127807A8 (en) Crystal structure of crispr cpf1
WO2019006471A3 (en) Novel crispr rna targeting enzymes and systems and uses thereof
WO2020086144A3 (en) APPLICATIONS OF CRISPRi IN HIGH THROUGHPUT METABOLIC ENGINEERING
CL2021002741A1 (en) A prevotella and francisella crispr protein 1 (cpf1) isolated from lachnospiraceae bacterium nd2006; fusion protein comprising it; nucleic acid; vector; methods for altering the genome of a cell or a double-stranded DNA molecule in vitro using such proteins (divisional de sol. 201903004)
MX2020011939A (en) Novel crispr enzymes and systems.
EP4253551A3 (en) Novel crispr dna and rna targeting enzymes and systems
WO2005012487A3 (en) Compositions and methods for preparing short rna molecules and other nucleic acids
EP4328303A3 (en) Novel use
WO2020178162A8 (en) Exocyclic amine substituted coumarin compounds and their uses as fluorescent labels
WO2007075626A3 (en) Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo tm) contiaining different lengths of palindromic segments
WO2011021102A3 (en) Compositions and methods for intramolecular nucleic acid rearrangement
MX2022011012A (en) Modified short interfering nucleic acid (sina) molecules and uses thereof.
WO2018146557A3 (en) Long double-stranded rna for rna interference
WO2016193351A3 (en) Recombinant microorganism for improved production of fine chemicals
WO2019055926A3 (en) Method for using aqueous two-phase system for the isolation, purification and/or concentration of short nucleic acid fragments
WO2017123758A8 (en) Compositions and methods for sequencing nucleic acids
WO2020150449A8 (en) Reaction schemes involving acids and bases; reactors comprising spatially varying chemical composition gradients; and associated systems and methods
WO2020198174A8 (en) Simultaneous multiplex genome editing in yeast
WO2021216776A3 (en) Capping compounds, compositions and methods of use thereof
WO2019147308A3 (en) Rna nanostructures and methods of making and using rna nanostructures
HUP0303517A2 (en) Nucleotide sequence mediating male fertility and method of using same
WO2023023285A3 (en) Methods and compositions relating to covalently closed nucleic acids
IL292053A (en) Compositions, methods and kits for biological sample and rna stabilization
MX2008004899A (en) Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22893875

Country of ref document: EP

Kind code of ref document: A2